Concepedia

Author

C Pasquinelli

Bristol-Myers Squibb (United States)

Also Known As

C G PASQUINELLI, C PASQUINELLI, C Pasquinelli, C. Pasquinelli, Claudio Pasquinelli

63

Publications

5.9K

Citations

28

H-Index

47

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Scripps Research InstituteUniversity of Colorado DenverInstitut PasteurInserm
CP

About

C Pasquinelli is an author at Bristol-Myers Squibb (United States) specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

20

3K

2

Natural Sciences

3

3

141

3

Cell Biology

2

2

112

4

Biochemistry

1

1

29

5

Endocrinology

1

1

29

C Pasquinelli

×

33

Publications

5.9K

Citations

28

H-Index

YearCitations

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres,

New England Journal of Medicine

2014

1.2K

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response

Barbara Rehermann, Carlo Ferrari, C Pasquinelli,

Nature Medicine

1996

845

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

Francis V. Chisari, Kathleen Klopchin, Takashi Moriyama,

Cell

1989

700

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

Anna S. Lok, David Gardiner, Eric Lawitz,

New England Journal of Medicine

2012

607

Hepatitis B virus persistence after recovery from acute viral hepatitis.

T.I. Michalak, C Pasquinelli, S Guilhot,

Journal of Clinical Investigation

1994

331

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.

Andreas Cerny, John G. McHutchison, C Pasquinelli,

Journal of Clinical Investigation

1995

322

Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection

Gregory T. Everson, Karen Sims, M. Rodríguez‐Torres,

Gastroenterology

2013

198

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

Anna S. Lok, David Gardiner, Christophe Hézode,

Journal of Hepatology

2013

138

Hepatitis C Virus Core and E2 Protein Expression in Transgenic Mice

C Pasquinelli, J M Shoenberger, J. Chung,

Hepatology

1997

137

Hepatitis B virus persistence after recovery from acute viral hepatitis.

T.I. Michalak, C Pasquinelli, S Guilhot,

Journal of Clinical Investigation

1994

137

Page 1